finasteride has been researched along with Adolescent Gynecomastia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Althof, S; Baas, WR; Butcher, MJ; Clemons, J; Delfino, K; Herberts, M; Holland, B; Kohler, TS; Lwin, A; McVary, KT | 1 |
| Bono, K; Imafuku, I; Kitamura, M; Nakayama, T; Tsuji, Y | 1 |
| Gilling, P; Morrill, B; Nickel, JC; Rittmaster, RS; Tammela, TL; Wilson, TH | 1 |
| Chung, DE; Kaplan, SA; Lee, RK; Scofield, S; Te, AE | 1 |
| Ellis, RJ; Lee, SC | 2 |
| Boni, S; Chiodera, P; Coiro, V; Maccarini, PA; Volpi, R | 1 |
| Fourcroy, JL; Green, L; Wysowski, DK | 1 |
| Edet, E; Freemantle, S; Mann, RD; Pearce, G; Stephens, MD; Wilton, L | 1 |
| Carlin, BI; Findlay, J; Resnick, MI; Seftel, AD | 1 |
| Lowe, FC; Staiman, VR | 1 |
| Gilhooly, P; Miller, JA; Pramanik, B | 1 |
| Sinclair, RD; Wade, MS | 1 |
| Cronin, D; Fogt, F; Lynch, R; Zimmerman, RL | 1 |
| Barbaud, A; Schmutz, JL; Trechot, P | 1 |
| Alsina, M; Bulla, F; Ferrando, J; Grimalt, R; Manasievska, E | 1 |
1 trial(s) available for finasteride and Adolescent Gynecomastia
| Article | Year |
|---|---|
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
Topics: 5-alpha Reductase Inhibitors; Aged; Azasteroids; Double-Blind Method; Dutasteride; Finasteride; Gynecomastia; Humans; Hypertension; Male; Middle Aged; Organ Size; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Treatment Outcome | 2011 |
15 other study(ies) available for finasteride and Adolescent Gynecomastia
| Article | Year |
|---|---|
A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.
Topics: 5-alpha Reductase Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Datasets as Topic; Dose-Response Relationship, Drug; Drug Eruptions; Fatigue; Finasteride; Gynecomastia; Hearing Disorders; Humans; Libido; Male; Memory Disorders; Middle Aged; Muscle Weakness; Prostatitis; Sexual Dysfunction, Physiological; Sleep Wake Disorders; United States; United States Food and Drug Administration | 2018 |
[Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan].
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Adult; Alopecia; Anticoagulants; Diffusion Magnetic Resonance Imaging; Drug Approval; Estradiol; Estrone; Finasteride; Gynecomastia; Humans; Japan; Male; Stroke; Thrombosis; Tomography, X-Ray Computed | 2014 |
A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Drug Substitution; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Gynecomastia; Humans; Libido; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies | 2012 |
Prevention of prostate cancer with finasteride.
Topics: 5-alpha Reductase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Prostatic Neoplasms | 2003 |
Male breast cancer during finasteride therapy.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Breast Neoplasms, Male; Carcinoma, Ductal; Doxazosin; Drug Labeling; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; United States | 2004 |
Case report: finasteride-induced gynecomastia in a 62-year-old man.
Topics: Dihydrotestosterone; Finasteride; Gynecomastia; Humans; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Testosterone | 1995 |
Gynecomastia and breast cancer during finasteride therapy.
Topics: Breast Neoplasms, Male; Finasteride; Gynecomastia; Humans; Male; Prostatic Hyperplasia | 1996 |
The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients.
Topics: Adolescent; Adult; Aged; Cohort Studies; Ejaculation; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Gynecomastia; Hair Diseases; Humans; Libido; Male; Middle Aged; Product Surveillance, Postmarketing; Prostatic Hyperplasia; Urination Disorders | 1996 |
Finasteride induced gynecomastia.
Topics: Aged; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Prostatic Hyperplasia | 1997 |
Tamoxifen for flutamide/finasteride-induced gynecomastia.
Topics: Aged; Androgen Antagonists; Drug Evaluation; Drug Therapy, Combination; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Finasteride; Flutamide; Gynecomastia; Humans; Male; Middle Aged; Prostatic Neoplasms; Tamoxifen; Testosterone; Time Factors | 1997 |
Waxing and waning gynecomastia: an indication of noncompliant use of prescribed medication.
Topics: 5-alpha Reductase Inhibitors; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Middle Aged; Patient Compliance; Prostatic Hyperplasia | 1999 |
Reversible painful gynaecomastia induced by low dose finasteride (1 mg/day)
Topics: Adult; Alopecia; Enzyme Inhibitors; Finasteride; Gynecomastia; Humans; Male; Pain | 2000 |
Cytologic atypia in a 53-year-old man with finasteride-induced gynecomastia.
Topics: Alopecia; Biopsy, Needle; Cell Nucleus; Cytoplasm; Finasteride; Gynecomastia; Humans; Male; Middle Aged; Vacuoles | 2000 |
[Gynecomastia and finasteride].
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Finasteride; Gynecomastia; Humans; Male; Prostatic Hyperplasia; Time Factors | 2001 |
Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Finasteride; Gynecomastia; Humans; Male | 2002 |